Streetbeat News

Analyst Ratings

PFBC

Stephens & Co. analyst Andrew Terrell has reiterated an Overweight rating on Preferred Bank (NASDAQ:PFBC) and maintained a $64 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:51 pm

OSBC

Stephens & Co. analyst Terry McEvoy has reiterated an Overweight rating on Old Second Bancorp (NASDAQ:OSBC) and maintained a price target of $18.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:51 pm

MRTN

Stephens & Co. analyst Jack Atkins has reiterated an Overweight rating on Marten Transport (NASDAQ:MRTN) and maintained a $27 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:50 pm

VZ

Wells Fargo analyst Eric Luebchow has maintained an Equal-Weight rating on Verizon Communications (NYSE:VZ) but lowered the price target from $40 to $36.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:49 pm

FULT

Stephens & Co. analyst Matt Breese has reiterated an Overweight rating on Fulton Financial (NASDAQ:FULT) and maintained a price target of $14.5.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:48 pm

T

Wells Fargo analyst Eric Luebchow has maintained an Overweight rating on AT&T (NYSE:T) but lowered the price target from $22 to $20.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:47 pm

FNB

Stephens & Co. analyst Russell Gunther has reiterated an Overweight rating on F N B (NYSE:FNB) and maintained a $15 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:47 pm

DFS

Stephens & Co. analyst Vincent Caintic has reiterated an Equal-Weight rating on Discover Financial Services (NYSE:DFS) and maintained a price target of $124.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:46 pm

CFG

Stephens & Co. analyst Terry McEvoy has reiterated an Overweight rating on Citizens Financial Group (NYSE:CFG) and maintained a $36 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:45 pm

AKYA

BKNG

EW

LAZR

PFE

STLA

SWAV

TRIP

VTS

Jim Cramer, on CNBC’s 'Mad Money Lightning Round', gave his opinions on several stocks. He prefers Booking Holdings over Tripadvisor, and recommends Edwards Lifesciences over Shockwave Medical. He described Akoya Biosciences as a speculative stock and predicted a downward trend for Luminar Technologies. He supports Vitesse Energy and Stellantis, and suggested Pfizer should better utilize its funds and work more with Nurtec.

Portfolio Pulse from Lisa Levin

July 20, 2023 | 12:45 pm